REQUEST A DEMO
Total
USD $0.00
Search more companies

Ino-Pharm D.O.O. Beograd (Serbia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Ino-Pharm D.O.O. Beograd Profile Updated: September 30, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Ino-Pharm D.O.O. Beograd is an enterprise located in Serbia, with the main office in Belgrade. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was incorporated on September 07, 2001. Ino-Pharm D.O.O. Beograd currently employs 21 (2024) people. The latest financial highlights indicate a net sales revenue increase of 28.05% in 2024. Its’ total assets recorded a growth of 26.39%. The net profit margin of Ino-Pharm D.O.O. Beograd increased by 0.18% in 2024.

Headquarters
Bore Stankovica 2
Belgrade; Belgrade;

Contact Details: Purchase the Ino-Pharm D.O.O. Beograd report to view the information.

Website: http://www.inopharm.net

Basic Information
Total Employees:
Purchase the Ino-Pharm D.O.O. Beograd report to view the information.
Registered Capital:
Purchase the Ino-Pharm D.O.O. Beograd report to view the information.
Financial Auditors:
Purchase the Ino-Pharm D.O.O. Beograd report to view the information.
Incorporation Date:
September 07, 2001
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Ino-Pharm D.O.O. Beograd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RSD. Absolute financial data is included in the purchased report.
Net sales revenue
28.05%
Total operating revenue
27.9%
Operating profit (EBIT)
27.09%
EBITDA
26.94%
Net Profit (Loss) for the Period
31.18%
Total Assets
26.39%
Total Equity
20.81%
Operating Profit Margin (ROS)
-0.07%
Net Profit Margin
0.18%
Return on Equity (ROE)
2.27%
Debt/Equity
-0.2%
Quick Ratio
-0.2%
Cash Ratio
-0.42%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?